Awak Overview

  • Founded
  • 2007
  • Status
  • Private
  • Employees
  • 63
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $40M
Latest Deal Amount
  • Investors
  • 4

Awak General Information


Developer of a portable and miniaturized dialysis system designed to offer treatment for renal diseases. The company's system uses sorbent technology which regenerates and reconstitutes used dialysis fluid into fresh fluid and provides the necessary clearances of the uremic toxins, enabling physicians to enhance the lives of dialysis patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 3 Tuas Lane
  • Singapore, 638612
  • Singapore
+65 6785 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Awak Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 13-Dec-2019 $40M 000.00 Completed Generating Revenue
1. Corporate 01-Dec-2016 000.00 000.00 Completed Generating Revenue
To view Awak’s complete valuation and funding history, request access »

Awak Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of a portable and miniaturized dialysis system designed to offer treatment for renal diseases. The company's s
Therapeutic Devices
Singapore, Singapore
63 As of 2021
0000000000 0 000.00


ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
0000000000 000000000
Helsinki, Finland
0 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Awak Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000 Accelerator/Incubator Backed Helsinki, Finland 0 000000000
You’re viewing 1 of 1 competitors. Get the full list »

Awak Executive Team (9)

Name Title Board Seat Contact Info
Suresha Venkataraya Chief Executive Officer & Board Member
Mandar Gori Director, Marketing & Business Development
Daniel Tan Director of Program Management and Operations
Joel Fernandes Director, Research & Development and Quality
Martin Roberts Ph.D Chief Scientist
You’re viewing 5 of 9 executive team members. Get the full list »

Awak Board Members (11)

Name Representing Role Since
Abel Ang Awak Chairman 000 0000
Chua Thiam Joo Awak Board Member 000 0000
Gordon Ku Ph.D Awak Owner & Chairman 000 0000
Jeffrey Chi Ph.D Self Board Member 000 0000
Lay-Tan Siok Lie Awak Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Awak Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Awak Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Advanced MedTech Holdings Corporation Minority 000 0000 000000 0
Enterprise Singapore Corporation Minority 000 0000 000000 0
Vickers Venture Partners Corporate Venture Capital Minority 000 0000 000000 0
Accuron Technologies PE-Backed Company Minority 000 0000 000000 0
To view Awak’s complete investors history, request access »